Caremark shareholders approve CVS merger
The PBM's shareholders vote in favor of CVS' roughly $26.7 billion offer during an investor meeting March 16. CVS will have to bridge two pharmacy models after close of the acquisition, which is expected the week of March 19. CVS has positioned the acquisition as an opportunity to transform the way pharmacy services are delivered by blurring the lines between traditional mail order and retail pharmacy services. Express Scripts, as part of a hostile takeover bid, has argued the fundamental differences between the two business models would plague a merger between Caremark and CVS (1"The Pink Sheet" Feb. 26, 2007, p. 17). In response to Express Scripts offer, CVS recently sweetened its offer to include a $7.50 one-time special dividend...
You may also be interested in...
The integration team handling CVS' merger with pharmacy benefit manager Caremark is focusing on the development of new products and services across both the PBM and retail businesses as part of its contract negotiations with health plans, Chief Executive Officer Tom Ryan said
A merger between pharmacy benefit manager Caremark and pharmacy chain CVS would be plagued by the same problems that vertical mergers involving PBMs have faced in the past, PBM Express Scripts argues in a pamphlet to Caremark shareholders
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.